(Q43083283)

13 November 2017

0 references

KRAS above and beyond - EGFR in pancreatic cancer (English)

1 reference

13 November 2017

Jens T Siveke

1

1 reference

13 November 2017

Howard C Crawford

series ordinal

2

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

13 November 2017

1 reference

13 November 2017

3

1 reference

13 November 2017

11

1 reference

13 November 2017

1262-1263

1 reference

EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

EGF receptor is required for KRAS-induced pancreatic tumorigenesis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717786

Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23174662

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.750

0 references

1 reference

13 November 2017

PubMed publication ID

23174662

1 reference